1. Home
  2. RMBS vs CORT Comparison

RMBS vs CORT Comparison

Compare RMBS & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rambus Inc.

RMBS

Rambus Inc.

HOLD

Current Price

$94.52

Market Cap

8.0B

Sector

Technology

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$80.13

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RMBS
CORT
Founded
1990
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
7.6B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
RMBS
CORT
Price
$94.52
$80.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
5
Target Price
$102.00
$139.00
AVG Volume (30 Days)
1.5M
690.9K
Earning Date
02-02-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
30.64
N/A
EPS
2.10
0.87
Revenue
$678,488,000.00
$741,172,000.00
Revenue This Year
$29.01
$23.79
Revenue Next Year
$16.02
$40.97
P/E Ratio
$44.84
$100.74
Revenue Growth
31.05
17.92
52 Week Low
$40.12
$49.00
52 Week High
$114.55
$117.33

Technical Indicators

Market Signals
Indicator
RMBS
CORT
Relative Strength Index (RSI) 44.66 47.54
Support Level $92.88 $81.31
Resistance Level $107.66 $89.00
Average True Range (ATR) 4.32 3.22
MACD -0.21 0.10
Stochastic Oscillator 13.31 21.65

Price Performance

Historical Comparison
RMBS
CORT

About RMBS Rambus Inc.

Rambus Inc is a semiconductor solutions provider offering high-speed, high-security computer chips and Silicon intellectual property. The company's key products include memory interface chips, built for high speed and efficiency; silicon IP, providing high-speed memory and chip-to-chip connection technology; and architecture licenses, which allow customers to use portions of Rambus' patented inventions for their own digital electronics. The firm receives the majority of its revenue from the United States, Taiwan, Asia, Japan, and Singapore.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: